Cellebrite DI (CLBT) EBT (2020 - 2025)

Cellebrite DI's EBT history runs 6 years deep, the most recent figure standing at $26.3 million for Q4 2025.

• On a quarterly basis, EBT rose 32.03% year-over-year to $26.3 million in Q4 2025; TTM through Dec 2025 was $90.7 million, a 132.86% increase from a year earlier, with the FY2025 full-year figure at $90.7 million, up 132.86% from the prior year.
• EBT rose to $26.3 million in Q4 2025 per CLBT's latest filing, from $24.3 million in the prior quarter.
• Across five years, EBT topped out at $54.5 million in Q1 2022 and bottomed at -$204.5 million in Q3 2024.
• The 5-year median for EBT is $11.9 million (2021), against an average of -$2.9 million.
• Across the five-year window, EBT soared 1045.68% in 2022 and sank 3086.38% in 2024, its largest moves.
• Year by year, EBT stood at $54.1 million in 2021, then plunged by 83.18% to $9.1 million in 2022, then plunged by 235.63% to -$12.3 million in 2023, then soared by 261.17% to $19.9 million in 2024, then soared by 32.03% to $26.3 million in 2025.
• Per Business Quant, the three latest CLBT EBT figures stand at $26.3 million (Q4 2025), $24.3 million (Q3 2025), and $20.8 million (Q2 2025).